Calithera Biosciences, Inc.
Hedge Funds Holdings
Last updated:
Calithera Biosciences, Inc.‘s stocks are currently a part of 52 hedge funds’ portfolios, which represents 57.46% of the total amount of its stocks outstanding. This makes up a total of 42.44M shares of Calithera Biosciences, Inc.. Compared to the previous quarter, the number grew by 4.41% or 1.79M shares more. As for the holding position changes, 23.08% (12) of current hedge fund investors increased the number of shares held, 21.15% (11) of current holders sold a part of the shares held, and 28.85% (15) closed the holdings completely. 13 hedge funds are new holders of Calithera Biosciences, Inc. stock in Q1 2022, it is 25% of total holders.
Hedge funds holding Calithera Biosciences (Q2 2017 – Q1 2022)
| Q2 2017 | 94 |
|---|---|
| Q3 2017 | 91 |
| Q4 2017 | 112 |
| Q1 2018 | 100 |
| Q2 2018 | 89 |
| Q3 2018 | 81 |
| Q4 2018 | 76 |
| Q1 2019 | 71 |
| Q2 2019 | 92 |
| Q3 2019 | 85 |
| Q4 2019 | 82 |
| Q1 2020 | 79 |
| Q2 2020 | 109 |
| Q3 2020 | 96 |
| Q4 2020 | 105 |
| Q1 2021 | 99 |
| Q2 2021 | 76 |
| Q3 2021 | 66 |
| Q4 2021 | 54 |
| Q1 2022 | 52 |
Hedge funds changes in Calithera Biosciences positions (Q2 2017 – Q1 2022)
| Q2 2017 | 38 | 35 | 13 | 17 | -9 |
|---|---|---|---|---|---|
| Q3 2017 | 14 | 35 | 26 | 16 | 0 |
| Q4 2017 | 36 | 38 | 23 | 15 | 0 |
| Q1 2018 | 13 | 36 | 31 | 22 | -2 |
| Q2 2018 | 15 | 25 | 34 | 26 | -11 |
| Q3 2018 | 9 | 24 | 28 | 17 | 3 |
| Q4 2018 | 9 | 24 | 28 | 13 | 2 |
| Q1 2019 | 4 | 30 | 17 | 10 | 10 |
| Q2 2019 | 27 | 36 | 16 | 4 | 9 |
| Q3 2019 | 13 | 38 | 21 | 20 | -7 |
| Q4 2019 | 11 | 38 | 21 | 14 | -2 |
| Q1 2020 | 13 | 30 | 25 | 13 | -2 |
| Q2 2020 | 38 | 49 | 15 | 8 | -1 |
| Q3 2020 | 14 | 26 | 40 | 26 | -10 |
| Q4 2020 | 25 | 30 | 35 | 16 | -1 |
| Q1 2021 | 16 | 36 | 33 | 20 | -6 |
| Q2 2021 | 14 | 23 | 29 | 37 | -27 |
| Q3 2021 | 6 | 24 | 22 | 15 | -1 |
| Q4 2021 | 9 | 19 | 17 | 20 | -11 |
| Q1 2022 | 13 | 12 | 11 | 15 | 1 |
Hedge funds changes in Calithera Biosciences stock options (Q2 2017 – Q1 2022)
| Q2 2017 | 1,216,000 | 3,012,000 |
|---|---|---|
| Q3 2017 | 1,420,000 | 2,038,000 |
| Q4 2017 | 768,000 | 855,000 |
| Q1 2018 | 536,000 | 923,000 |
| Q2 2018 | 535,000 | 720,000 |
| Q3 2018 | 494,000 | 277,000 |
| Q4 2018 | 71,000 | 12,000 |
| Q1 2019 | 1,747,000 | 369,000 |
| Q2 2019 | 444,000 | 162,000 |
| Q3 2019 | 127,000 | 218,000 |
| Q4 2019 | 268,000 | 430,000 |
| Q1 2020 | 465,000 | 330,000 |
| Q2 2020 | 386,000 | 467,000 |
| Q3 2020 | 193,000 | 37,000 |
| Q4 2020 | 11,581,000 | 11,708,000 |
| Q1 2021 | 1,148,000 | 598,000 |
| Q2 2021 | 1,142,000 | 171,000 |
| Q3 2021 | 1,230,000 | 330,000 |
| Q4 2021 | 236,000 | 55,000 |
| Q1 2022 | 139,000 | 3,000 |